Digirad Financial Ratios

Digirad Corporation -- USA Stock  

USD 2.3  0.05  2.13%

We urge you to utilize analysis of Digirad fundamentals to see if markets are presently mispricing the company. We found thirty-seven available fundamental indicators for Digirad Corporation which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Digirad fundamentals including its Shares Outstanding, Price to Sales, Cash per Share, as well as the relationship between Number of Shares Shorted and EBITDA . Please also check Digirad Corporation Price to Earning to verify the company can sustain itself down the road.Use Digirad to protect against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Digirad to be traded at $2.21 in 30 days

Digirad Valuation Over Time

Enterprise Value

Digirad Company Summary

Digirad competes with Edwards Lifesciences, DarioHealth Corp. Digirad Corporation operates in two segments Diagnostic Services and Diagnostic Imaging. The Diagnostic Services segment offer inoffice nuclear cardiology and ultrasound services and cardiac event monitoring services to physicians who perform nuclear imaging echocardiography vascular or general ultrasound tests or any combination of these procedures in their offices hospitals and imaging centers. The Diagnostic Imaging segment sells nuclear imaging cameras for nuclear cardiology and general nuclear medicine applications as well as offer camera maintenance services to hospitals imaging centers physician offices and mobile service providers. Digirad Corporationration was founded in 1985 and is headquartered in Suwanee Georgia.

Digirad Return On Equity vs Shares Outstanding

Digirad Corporation is rated # 2 in return on equity category among related companies. It is rated # 2 in shares outstanding category among related companies .

Digirad Fundamentals

 Better Than Average     
 Worse Than Average Compare Digirad to competition
FundamentalsDigiradPeer Average
Return On Equity(5.01) % (15.17) %
Return On Asset0.8 % (15.64) %
Profit Margin(2.6) % (5.5) %
Operating Margin1.1 % (10.91) %
Current Valuation63.99 M152.14 B
Shares Outstanding19.98 M1.43 B
Shares Owned by Insiders5.11 % 6.91 %
Shares Owned by Institutions53.85 % 18.37 %
Number of Shares Shorted89.45 K3.24 M
Price to Earning(14.47) times40.69 times
Price to Book0.76 times14.44 times
Price to Sales0.38 times17.81 times
Revenue121.09 M9.85 B
Gross Profit35.77 M21.75 B
EBITDA11.54 M1.41 B
Net Income(3.15 M)517.71 M
Cash and Equivalents1.97 M3.89 B
Cash per Share0.1 times5.17 times
Total Debt20.01 M7.36 B
Debt to Equity33 % 0.72 %
Current Ratio1.31 times3.3 times
Book Value Per Share3.03 times13.64 times
Cash Flow from Operations10.53 M1.25 B
Short Ratio2.27 times2.09 times
Earnings Per Share(0.16) times2.3 times
Price to Earnings To Growth(0.76) times1.22 times
Number of Employees32310.67 K
Market Capitalization45.95 M29.78 B
Total Asset64.11 M126.86 B
Retained Earnings(93.74 M)38.24 B
Working Capital23.04 M3.58 B
Current Asset31.75 M36.8 B
Current Liabilities8.71 M33.34 B
Z Score0.8708.73
Last Dividend Paid0.22
< 51% 

Chance of Financial Distress

Digirad Corporation has more than 51 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info


Digirad Growth Changes

EPS Diluted Growth

EPS Growth

NCFO Growth


Compare Digirad To Peers
Matt Molchan President CEO, Director
Jeffrey Eberwein Chairman of the Board, MBA
More Executives

Opportunity Range

October 23, 2017 Opportunity Range